Trial Profile
Effect of BIA 3-202 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 May 2016
Price :
$35
*
At a glance
- Drugs Nebicapone (Primary) ; Warfarin
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Sponsors Bial
- 30 May 2016 New trial record